Abstract
Continuous intrathecal baclofen infusion via a subcutaneously implanted programmable pump has been used in the treatment of severe spasticity. Improvement classically concerns the neurological (hypertonia, spasms, hyperreflexia), urological (bladder function) and other clinically relevant outcomes, such as functional status of daily living. This short note reports on another effect of intrathecal baclofen on vasomotor disorders and cyanosis in the lower limbs, described in a patient with spastic paraplegia.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rode, G., Mertens, P., Beneton, C. et al. Regression of vasomotor disorders under intrathecal baclofen in a case of spastic paraplegia. Spinal Cord 37, 370–372 (1999). https://doi.org/10.1038/sj.sc.3100838
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.sc.3100838